Study models advantages, harms, and affordability of WHO proposed cervical cancer screening strategies for women in LMICs

The harms, benefits, and affordability of seven primary screening algorithms for human papillomavirus (HPV).

New cancer drug shows encouraging results in Phase I/II trial

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced

September 14, 2024

Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital | Psychedelic Finance

KELOWNA, BC / ACCESSWIRE / May 24, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) (“Tryp” or the “Company”), a clinical-stage biotechnology company focused on developing intravenous-infused

June 9, 2023

Minimizing risks in pharmaceutical supply chains: what you need to know – Pharmaceutical Technology

Having a specialty logistics partner that can act as lookout for pharmaceutical manufacturers is critical in a world of supply chain uncertainty. Credit: Gorodenkoff/Shutterstock Pharmaceutical

September 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.